Dow Up0.12% Nasdaq Up1.35%

Enzo Biochem Inc. (ENZ)

-NYSE
4.88 0.03(0.62%) Oct 20, 4:02PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJul 31, 2014Jul 31, 2013Jul 31, 2012
Total Revenue 95,947   93,707   103,083  
Cost of Revenue54,268  54,835  55,973  
Gross Profit 41,679   38,872   47,110  
Operating Expenses
Research Development3,141  3,889  6,293  
Selling General and Administrative41,801  43,654  47,928  
Non Recurring6,917  10,309  33,368  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (10,180) (18,980) (40,479)
Income from Continuing Operations
Total Other Income/Expenses Net483  85  (463)
Earnings Before Interest And Taxes(9,905)(18,949)(40,921)
Interest Expense -   -   -  
Income Before Tax(9,905)(18,949)(40,921)
Income Tax Expense72  (712)(1,652)
Minority Interest -   -   -  
Net Income From Continuing Ops(9,977)(18,237)(39,269)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (9,977) (18,237) (39,269)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (9,977) (18,237) (39,269)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.